Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/entry-of-biogenerics-and-) was not found.

Search biology technology 1 entry of biogenerics and at Google

Search biology technology 1 entry of biogenerics and at Yahoo

Search biology technology 1 entry of biogenerics and at Msn

Google
 
(Date:7/29/2010)... is available in German . , Bremerhaven, ... and Marine Research in the Helmholtz Association for the ... an under-ice mission at about 79 North. The four-metre-long, ... icebreaker Polarstern under heavy pack ice. The vehicle was ... of the world,s first working groups to have successfully ...
(Date:7/29/2010)... 2010) Polymer strands wriggle their way through nanometer-sized ... there and do their jobs. New theoretical research by ... takes. , That,s a good thing to know ... proteins -- all of which count as polymers -- ... biosensors or as drug-delivery devices. , Researchers ...
(Date:7/29/2010)... than a bullet-proof vest yet synonymous with beauty and ... remarkable properties have yet to be fully replicated in ... properties as well as their looks, silk fibers have ... armor for 5,000 years. , Silk spun by ... This one-two punch is unmatched by synthetics, even though ...
Breaking Biology News(10 mins):Highlight of the Polarstern expedition 2Polymer passage takes time 2Behind the secrets of silk lie high-tech opportunities 2AngioDynamics 26apos 3B VenaCure EVLTTM System for Varicose Veins To Be Featured On 26apos 3BThe Doctors 26apos 3B National Television Program 71245 1AngioDynamics 26apos 3B VenaCure EVLTTM System for Varicose Veins To Be Featured On 26apos 3BThe Doctors 26apos 3B National Television Program 71245 2AngioDynamics 26apos 3B VenaCure EVLTTM System for Varicose Veins To Be Featured On 26apos 3BThe Doctors 26apos 3B National Television Program 71245 3AngioDynamics 26apos 3B VenaCure EVLTTM System for Varicose Veins To Be Featured On 26apos 3BThe Doctors 26apos 3B National Television Program 71245 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 8631 1Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 8631 2Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 8631 3Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 8631 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 8631 5National Accident Helpline Launches Specialist Claims Advice Websites 71241 1National Accident Helpline Launches Specialist Claims Advice Websites 71241 2
(Date:7/29/2010)... NY, July 30, 2010Thirty million women will benefit from ... either through new or strengthened insurance coverage, according to ... first analysis of its kind, the authors report that ... to health costs that women now experience by subsidizing ... women, and strengthening existing coverage for 14.5 million women ...
(Date:7/29/2010)... Researchers seeking to learn more about stroke by studying how ... week releasing new findings that they hope will aid in ... , The Japanese team is reporting in a ... they are optimistic that inhibiting a protein found on the ... irregular blood clotting and the spread of certain cancers throughout ...
(Date:7/29/2010)... the first time a cell-of-origin for human prostate ... predictive and diagnostics tools and the development of ... disease. , The researchers, from UCLA,s Jonsson Comprehensive ... benign prostate tissue could become human prostate cancer ... that bucks conventional wisdom. It had been widely ...
(Date:7/29/2010)... and Drug Administration (FDA) received reports of malignancies in ... concerns of an associated risk and prompting an investigation. ... reports of malignancy in children using infliximab, etanercept, and ... issue of Arthritis & Rheumatism , a journal ... FDA has approved 3 TNF blockers for use in ...
(Date:7/29/2010)... brain cells remain diverse and "fit" enough for storing ... Neuron , a new study led by Dr. Inna ... Aviv University describes what makes some memories stick. , ... that occurs in the brain, which could be the ... can generate, the new study has found. The understanding ...
Breaking Medicine News(10 mins):Health News:30 million women to benefit from health reform law 2Health News:30 million women to benefit from health reform law 3Health News:30 million women to benefit from health reform law 4Health News:Snake venom studies yield insights for development of therapies for heart disease and cancer 2Health News:Snake venom studies yield insights for development of therapies for heart disease and cancer 3Health News:Snake venom studies yield insights for development of therapies for heart disease and cancer 4Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 3Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:Memory's master switch 2Health News:Memory's master switch 3
... automated solution for cell culture work. ... cell-line maintenance, expansion, harvesting and plating. ... upon standard, industry proven components: ... capable of both rapid bulk media ...
... Serial Analysis of Gene Expression (SAGE) ... technology. Agencourt offers a cost-effective outsourcing ... and LongSAGE libraries. Agencourt's SAGE sequencing ... project turnaround and long Phred20 read ...
High-throughput DNA preparation and end sequencing of BAC libraries. 3730xl DNA sequencers. LIMS tracking utilizing Geospiza's Finch system. Full-length BAC sequencing also available. Our expertise h...
... DNA sequencing is the experimental process of ... region. The automated DNA Sequencing is based ... DNA polymerase, which allows cycle sequencing reactions. ... detected in a capillary instrument controlled by ...
Biology Products:
... is a formulation of iopamidol ... by oral administration or, where necessary, ... considerable improvement in the radiological exploration ... traditional contrast media. Thanks to its ...
... dimeglumine) is a paramagnetic MRI contrast agent. ... gadobenate, a chelating agent that forms a ... ion. It is salified with meglumine forming ... all the physico-chemical features typical of gadolinium ...
... GastroMARK (generic name: ferumoxsil) is Advanced ... distinguish the loops of the bowel from ... of organs and tissues in the abdomen ... organs and tissues cannot be easily distinguished ...
... Up to 20% of the ... the U.S. are suboptimal. Activated DEFINITY ... clearer images of the heart than ... activated DEFINITY improves diagnostic quality for ...
Medicine Products:
(Date:7/29/2010)... 29, 2010 CMP Therapeutics ... Dr Neill Moray Mackenzie to the role ... CMPT a long record of executive,board level ... companies including Cambridge Genetics Ltd, Oxford Biomedica ... Immunocore) and most recently as the SVP ...
(Date:7/28/2010)... Isolux Corsan has signed a contract,with the ... for the construction of an industrial complex under a turnkey ... cane, with a,processing capacity of 2,100,000 tons of cane per ... waste and other facilities for the milling,distillation and production of ... , , ...
(Date:7/28/2010)... VIASPACE Inc. (OTC Bulletin Board: VSPC), a clean energy company ... reported that Chief Executive Dr. Carl Kukkonen made ... Industrial Biotechnology held in Dalian, China , July ... leaders, technical experts, government officials and investors attended from around ... , , ...
(Date:7/27/2010)... July 27 ... to optimize clinical trial enrollment for life sciences ... won a CIO 100 award based on their ... here: http://www.cio.com/cio100/detail/2072 ). StudyOptimizer is a web-based ... and tracking of patient enrollment for global clinical ...
Breaking Biology Technology:CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO 2CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO 3CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO 4CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO 5Isolux Corsan Awarded a Contract for the Construction of an Ethanol Plant in Colombia 2Isolux Corsan Awarded a Contract for the Construction of an Ethanol Plant in Colombia 3VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China 2VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China 3VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China 4Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView 2
(Date:7/29/2010)... Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host ... issuance of Q2 financial results on Monday, August 16, 2010 . ... Conference Call Information ... To access the ... United States and Canada or +1 212 231 2901 ...
(Date:7/29/2010)... response to the agreement announced that CVS Caremark would provide pharmacy ... the National Community Pharmacists Association (NCPA) issued the following statement from ... H. Harmison , PD: , ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) , ...
(Date:7/29/2010)... , July 29 ... from a Phase Ib/II clinical trial in ... unique, investigational new drug for the treatment ... endpoint demonstrating that ITI-007 was safe and ... addition, several exploratory endpoints were evaluated. Treatment ...
Breaking Medicine Technology:Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3NCPA Statement on CVS Caremark-Aetna Agreement 2NCPA Statement on CVS Caremark-Aetna Agreement 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 2Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 4Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 5Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 6Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 1Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 2Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 3Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 4Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 5MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 1MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 2MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 3New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 1New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 2New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 3